8121
-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Neuropsychiatric Disease and Treatment
(2,364,827) Views
Editor in Chief Dr Roger M Pinder
1176-6328
OtherMilnacipran: recent findings in depression
Guest editors: Stuart Montgomery (London, UK) and Mike Briley (Castres, France)
Neuropsychiatric Disease and Treatment 2010, 6:0-0
24 August 2010
Perspectives
Editorial Foreword - Milnacipran: recent findings in depression
Stuart Montgomery, Mike Briley
Neuropsychiatric Disease and Treatment 2010, 6:1-2
24 August 2010
Review
Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
Philippe Courtet
Neuropsychiatric Disease and Treatment 2010, 6:3-8
24 August 2010
Review
Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
Peter Hofmann
Neuropsychiatric Disease and Treatment 2010, 6:9-15
25 August 2010
Review
Antidepressant therapy with milnacipran and venlafaxine
Lucilla Mansuy
Neuropsychiatric Disease and Treatment 2010, 6:17-22
25 August 2010
Review
Milnacipran: a unique antidepressant?
Siegfried Kasper, Gerald Pail
Neuropsychiatric Disease and Treatment 2010, 6:23-31
25 August 2010
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
